Harrow · 1 hour ago
Gross to Net Analyst
Harrow Health is a leading North American ophthalmic-focused pharmaceutical company, committed to innovation and patient access to affordable medicines. The Gross-to-Net Analyst plays a critical role in supporting the development and accuracy of GTN models and revenue accounting processes, ensuring all deductions from gross sales are accurately forecasted and reconciled.
BiotechnologyHealth CareMedical
Responsibilities
Support monthly, quarterly, and annual GTN forecasts, including scenario modeling for pricing, volume, and payer mix changes
Develop and maintain GTN models in collaboration with FP&A and Accounting to ensure accurate revenue forecasting
Prepare analysis of GTN drivers, accruals, and true-ups by product, channel, and payer type
Perform variance analysis (forecast vs. actuals) to identify trends and insights impacting gross margins
Work with Accounting during close cycles to validate GTN accruals, true-ups, and revenue recognition per ASC 606
Reconcile forecasted and actual deductions monthly; document assumptions and adjustments
Ensure appropriate SOX and internal control compliance for GTN-related accounts
Analyze and track rebate and chargeback claims to ensure accuracy and compliance with contractual terms
Provide financial insight to pricing and market access teams for new contracts, launches, or payer strategies
Support commercial and government price reporting (ASP, AMP, Best Price) by providing GTN inputs and analytics
Maintain accuracy of GTN data sources partnering with 3rd party service provider, RSM (ERP, EPM, and BI tools such as Oracle PBCS, Microsoft Power BI)
Partner with IT/Finance Systems to automate GTN workflows and reporting dashboards
Develop standardized templates and reporting packages to streamline GTN processes
Qualification
Required
Bachelor's degree in Finance, Accounting, Economics, or related field
3–5 years of experience in financial analysis, accounting, or revenue operations; ideally in pharmaceutical or life sciences industries
Working knowledge of pharma gross-to-net components (rebates, chargebacks, returns, distribution fees, etc.)
Familiarity with revenue recognition (ASC 606) and government pricing concepts (ASP, AMP, Medicaid, Medicare)
Advanced Excel and proficiency with financial systems (Oracle, Power BI, or similar)
Strong analytical and quantitative skills, with attention to accuracy and detail
Excellent written and verbal communication; ability to summarize complex data clearly
Cross-functional collaboration skills with Accounting, Market Access, and Commercial teams
Comfortable working in a fast-paced, growth-oriented environment
Company
Harrow
Harrow (NASDAQ: HROW) is a growing leader in the ophthalmic healthcare market.
Funding
Current Stage
Public CompanyTotal Funding
$533.75MKey Investors
Oaktree Capital ManagementSWK Funding
2025-09-08Post Ipo Debt· $250M
2023-07-19Post Ipo Equity· $60M
2023-03-28Post Ipo Debt· $100M
Leadership Team
Recent News
2025-02-12
2025-02-12
Company data provided by crunchbase